Cargando…

Risks of hydroxychloroquine use for COVID-19 prophylaxis

Detalles Bibliográficos
Autores principales:	Sachdeva, Muskaan, Shah, Monica, Ziv, Michael, Leshem, Eyal, Dodiuk-Gad, Roni P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195137/ https://www.ncbi.nlm.nih.gov/pubmed/32348818 http://dx.doi.org/10.1016/j.jaad.2020.04.111

Ejemplares similares

Cutaneous manifestations of COVID-19: Report of three cases and a review of literature
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

COVID-19 and racial disparities
por: Shah, Monica, et al.
Publicado: (2020)

Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
por: Grant-Kels, Jane M.
Publicado: (2020)

Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
por: Sachdeva, Muskaan, et al.
Publicado: (2020)

Eating disorders in the age of COVID-19
por: Shah, Monica, et al.
Publicado: (2020)

Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy
por: Gianotti, Raffaele, et al.
Publicado: (2020)

A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy
por: Parisi, Rose, et al.
Publicado: (2023)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management
por: Parisi, Rose, et al.
Publicado: (2023)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
por: Faruqui, Atiya R., et al.
Publicado: (2021)

LEPOARD syndrome: A report of a case with a novel PTPN11 mutation
por: Rahal, Nader, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right
por: Garg, Rakesh, et al.
Publicado: (2022)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
por: Yang, Alexander, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

Toxic epidermal necrolysis–like dermatomyositis associated with antimelanoma differentiation antigen 5
por: Kushnir-Grinbaum, Daniella, et al.
Publicado: (2018)

Optimizing care for atopic dermatitis patients during the COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020)

The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
por: Shah, Shagun B., et al.
Publicado: (2020)

Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS
por: Stirton, Hannah, et al.
Publicado: (2022)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

Work impairment in a woman with severe hidradenitis suppurativa after delayed diagnosis: A call for action
por: Shah, Monica, et al.
Publicado: (2020)

Adverse Medication Reactions
por: Dodiuk-Gad, Roni P., et al.
Publicado: (2017)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed()
por: Tahiri Joutei Hassani, Rachid, et al.
Publicado: (2020)

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
por: Singh, Harmanjit, et al.
Publicado: (2021)

Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India
por: Mukhopadhyay, Sandip, et al.
Publicado: (2021)

Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
por: Rojas-Serrano, Jorge, et al.
Publicado: (2022)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Modifications to dermatology residency education during the COVID-19 pandemic
por: Mufti, Asfandyar, et al.
Publicado: (2020)

Risk of using hydroxychloroquine as a treatment of COVID-19
por: Alanagreh, Lo’ai, et al.
Publicado: (2020)

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19
por: Zhanel, George G., et al.
Publicado: (2021)

COVID-19 and wound care: A Canadian perspective
por: Mufti, Asfandyar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uvcvsais1avhmh03od9u7632tr